Presenilin 1 (PS1), a causative molecule of familial Alzheimer's disease (AD), is known to be an unprimed substrate of GSK3 (Twomey et al. 2006) and is phosphorylated at serine 353, 357 residues in its cytoplasmic loop region (Kirschenbaum et al. 2001) . In this report, we investigated the effect of PS1 phosphorylation on AD pathophysiology and obtained two important results -PS1 phosphorylation increased A42/40 ratio, and PS1 phosphorylation was enhanced in the human AD brains. Interestingly, we demonstrated that PS1 phosphorylation promoted Insulin Receptor (IR) cleavage and the IR intracellular domain (IR ICD) generated by γ-secretase led to a marked transactivation of Akt (PKB), which down-regulated GSK3activity. Thus, the cleavage of IR by γ-secretase can inhibit PS1 phosphorylation in the long run. Taken together, our findings indicate that PS1 phosphorylation at serine 353, 357 residues can play a pivotal role in the pathology of AD and that the dysregulation of this mechanism may be causally associated with its pathology.
Introduction
Alzheimer's disease (AD) is pathologically characterized by amyloid plaques and neurofibrillary tangles (NFTs). Amyloid plaques are composed of amyloid (A) peptides, which are derived from amyloid precursor protein (APP) via proteolytic cleavage by γ-secretase (De Strooper et al. 1998) . γ-Secretase is an enzymatic complex composed of at least four proteins: Presenilin 1 or Presenilin 2 (PS1 or PS2), Nicastrin, Pen 2, and Aph 1, with Presenilin representing the catalytic core (Yu et al. 2000; Francis et al. 2002; Goutte et al. 2002) . PS1 mutations account for the majority of cases of familial AD, and more than 170 pathogenic mutations have been identified within the PS1 coding sequence. On the other hand, NFTs are characterized by the accumulation of hyperphosphorylated Tau in neurons (Grundke-Iqbal et al. 1986 ). One of the candidates which phosphorylate Tau is Glycogen synthase kinase 3  (GSK3) (Hanger et al. 1992 ).
GSK3 originally known to inactivate glycogen synthesis, is a serine/threonine protein kinase with a wide variety of substrates, and is expressed in various tissues with the highest level in the brain (Grundke-Iqbal et al. 1986 ). Interestingly, GSK3 phosphorylates not only Tau but also PS1 at serine 353, 357 residues in its cytoplasmic loop region (Kirschenbaum et al. 2001 , Twomey et al. 2006 . Therefore, it is intriguing to examine the function of PS1 phosphorylation at those residues to connect two AD hallmarks amyloid plaques and NFTs. Although our recent report demonstrated that GSK3mediated PS1 phosphorylation regulates the localization of γ-secretase and inhibits its N-cadherin cleavage (Uemura et al. 2007 ), a direct impact of PS1 phosphorylation on AD pathogenesis has not been elucidated so far.
Here, we demonstrate that GSK3mediated PS1 phosphorylation inhibits APP cleavage by γ-secretase activity and decreases the total A production whereas it increases A 42/40 ratio. Importantly, we found that PS1 phosphorylation was enhanced in the human AD brains. To further elucidate the underlying mechanisms which regulate PS1 phosphorylation, we focused on insulin signaling. We observed that phosphorylated PS1 4 promotes the cleavage of IR by γ-secretase activity. Intracellular domain of IR (IR ICD), produced by the cleavage, enhances the transcription of Akt (PKB), leading to inhibit GSK3 activity. Therefore, we propose that PS1, localized downstream of GSK3, may play a pivotal role in A production under the influence of insulin signaling, a mechanism that may be deeply associated with AD pathophysiology.
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Experimental procedures
Human brain samples
From the brain tissue collection in Tokyo Institute of Psychiatry (H.A.), which mainly consists of cases from psychogeriatric wards, we employed experiments of six dementia patients' brains with CERAD plaque score 'C' (Mirra et al. 1991) and Braak and Braak's neurofibrillary tangles (NFTs) stage IV or higher (Braak and Braak 1991) , as those with AD, as well as five control subjects without neurological complications (Table) . Fresh-frozen samples were taken in all cases from the mediobasal temporal neocortex. The brain samples were extracted in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1%
Triton X100, 1% NP-40, 0.5% Deoxycholate, 0.1% SDS, pH 8.0) with protease inhibitor cocktail (Roche) and sufficiently homogenized on ice. Then the samples were incubated for one night at 4ºC and centrifuged at 14,000 g × 20 min. The supernatants were directly used for Western blot analysis. All autopsies were undertaken with written consents and the study was approved by the official ethical committees of Kyoto University as well as of Tokyo Institute of Psychiatry.
Plasmid constructs
The pcDNA3.1-hIR (human Insulin Receptor) construct was a kind gift from Dr. Ikeuchi (Niigata University, Japan) (Ebina et al. 1985) . The cDNA encoding the IR ICD was generated by polymerase chain reaction (PCR)  using  the  following  primers:  IR  ICD  forward,   CGGGTACCCGCCATGAGAAAGAGGCAGCCAGA,  and  IR  ICD  reverse, CGGGATCCGGAAGGATTGGACCGAGGCAA. The PCR product was subcloned into the reading frame of the Kpn1/BamH1 sites of the pcDNA3 with HA tag vector. The construction of the plasmids expressing wt PS1, pseudo-phosphorylation PS1 (S353/357D PS1), deletion mutant PS1 (Δ340-350 PS1), and dominant negative PS1 (D385A PS1) was described previously (Uemura et al. 2003; Uemura et al. 2007) . Precise cloning of all reading frames was verified by sequencing.
Cell culture and transfection
SH-SY5Y (derived from human neuroblastoma) cells were maintained in Opti-MEM containing 10 % fetal bovine serum (FBS) (Invitrogen). Establishment of cell lines which stably express hIR was described previously (Maesako et al. 2010 TransFectin reagent (Bio-Rad) were mixed into 1 ml of serum-free medium and incubated for 20 min, then added directly to confluent cells in 2 ml of serum-containing medium. 24 to 48 hrs after transfection, reporter gene activity was assayed.
Antibodies and chemical reagents
Anti-IR, a monoclonal antibody recognizing the C-terminal amino acid residues of human IR, was from Neo Markers. Rabbit polyclonal anti-Akt and phospho-GSK3 (S9) were from Cell Signaling Technology. 
Western blotting
Cells were washed in phosphate-buffered saline (PBS) two times and scraped off. Cell pellets were suspended in ice-cold TNE buffer (10 mM Tris HCl, 150 mM NaCl, 1% NP-40, 1 mM EDTA pH 7.8),
supplemented with protease inhibitor cocktail, and briefly subjected to sonication. The samples were centrifuged at 14,000 g × 20 min at 4°C and the supernatants were collected to obtain protein samples.
The protein concentration was determined using the Bradford assay (Bradford 1976) . Protein samples were diluted with sample buffer (125 mM Tris, 4% SDS, 2% 2-mercaptoethanol, 20% glycerol and 0.01% bromophenol blue, pH 6.8) and denatured at 95°C for 5 min. Samples containing equal amounts of protein were electrophoresed on polyacrylamide gradient gels (5-20%) (Atto, Japan) in running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS). In this gel, APP CTFs bands were shown as a single band. To detect AICD, samples were electrophoresed on 15% Tricine gels (Atto, Japan) in Tricine SDS Running
Buffer. Immunoblotting was carried out by transferring the proteins to polyvinylidene difluoride microporous membrane, blocking this membrane with 5% skimmed milk in 20 mM TBS containing 0.1%
Tween 20 (TBS-T), and incubating with the primary antibodies in PBS containing 4% bovine serum albumin (BSA) (Nacalai tesque) overnight at 4°C. The membranes were then washed in TBS-T and incubated with a horseradish peroxidase-conjugated anti-mouse IgG (GE Healthcare) in TBS-T for 1 hr at room temperature. The specific reaction was visualized using the enhanced chemiluminescence (ECL) method (GE Healthcare).
In vitro γ-secretase assay
To analyze AICD or IR ICD level by in vitro γ-secretase assay (Sastre et al. 2001) , cells were suspended (0.5 ml/10 cm dish) in homogenization buffer (10 mM MOPS, 10 mM KCl, pH 7.0) and homogenates and the post-nuclear supernatant (PNS) were prepared as described (Steiner et al. 1998 ).
Membranes were pelleted from the PNS by centrifugation for 20 min at 16,000 g at 4°C, washed with homogenization buffer and resuspended (50 µl/10 cm dish) in assay buffer (150 mM sodium citrate, pH 6.4). To allow generation of ICD, samples were incubated at 37°C for 2 hrs in a volume of 25 µl/ assay.
Control samples were kept at 4°C. After termination of the assay reactions, samples were separated into pellet fractions (membrane fractions) and supernatant fractions by ultracentrifugation for 1 hr at 100,000 g at 4°C. AICD was detected using polyclonal anti-APP C-terminal antibody and IR ICD was detected using monoclonal anti-IR C-terminal antibody.
Immunostaining
5.0 × 10 4 cells were harvested onto 0.1% polyethyleneimine-coated Lab-Tek II Chamber slides (4-well; Nalge Nunc International, Rochester) and maintained in Opti-MEM containing 10% FBS. Cells were cultured for the indicated time and then fixed with 4% paraformaldehyde for 20 min. Fixed cells were blocked with PBS containing 0.2% Triton X-100 for 15 min and incubated overnight at 4°C with each antibody diluted in PBS containing 3% BSA. Immunoreactivity was visualized using the species-specific secondary antibodies mentioned above. The samples were examined using a laser confocal scanning microscope, LSM 510 Pascal (Zeiss).
Measurement of extracellular A
The levels of Aβ 40 and Aβ 42 were measured by ELISA kits specific to Aβ 40 and Aβ 42 (Wako, Japan), as described previously (Uemura. et al 2009) . Briefly, APPsw/Ncad-CHO cells were cultured in 6 cm dishes at a density of 7.0 × 10 5 cells /well. 24 hrs after incubation, the cells were treated with reagents for 5 hrs in DMEM/F-12 medium, followed by replacing DMEM/F-12 with 6 ml of Opti-MEM. 1 hr after replacing, 1 ml of medium was collected, centrifuged at 600 g for 5 min, and 100 µl of the aliquot was used for measurement of extracellular Aβ. 
MTT assay
The viability in APPswe/N-cad-CHO cells was analyzed by MTT assay using MTT Cell Proliferation Assay Kit (Cayman Chemical Company, USA). Briefly, cells were cultured in a 96-well plate at a density of 1.0 × 10 4 cells /well. 24 hrs after incubation, reagents of indicated concentration were treated for 5 hrs in the presence of DMEM/F-12 medium, followed by replacing DMEM/F-12 to 100 μl of Opti-MEM with the reagents. 1 hr after replacing, MTT was measured using the Kit and microplate reader.
Real-time PCR assay
Total RNA was isolated using ISOGEN (NIPPON GENE, Japan), according to the manufacture's protocol.
For real-time PCR analysis, 5 µg total RNA from each sample was used for cDNA synthesis kit (GE Healthcare). Real-time PCR primers were designed as follows: Akt1: fw GACCTCAAGCTGGAGAAC / rv ACTGCACGGCCGTAGTC, Akt2: fw ACCGCCTGTGCTTTGTGATG / rv TCATTGTCCTCCAGCACCTC Akt3: fw CATTATTGCAAAGGATGAAGTGGCAC / rv CCAGCATTAGATTCTCCAACTTGAG.
For the amplification of Akt, 5 µl of cDNA was added to the SYBR green master mix (Roche) and real-time PCR assay was performed in LightCycler 480 (Roche).
Statistical analysis
All values are given in means ± SE. Comparisons were performed using an unpaired Student's t-test. For comparison of multiparametric analysis, one-way factorial ANOVA, followed by the post hoc analysis by Fisher's PLSD was used. p < 0.05 was considered to indicate a significant difference. n = 4 indicated four independent experiments.
Results
PS1 phosphorylation inhibits APP cleavage but enhances extracellular A42/40 ratio
Since PS1 is known to be the essential component of γ-secretase, we examined the effect of its phosphorylation on APP cleavage. To test this, we transfected wt PS1 and pseudo-phosphorylated PS1 mutant S353/357D PS1 (in which serine residues phosphorylated by GSK3 are substituted with aspartate to mimic phosphorylation state (Uemura et al. 2007 )) into MEF PS-/-cells. Transfected cells were treated with insulin to promote ectodomain shedding (Linda et al. 2007) and to inhibit the phosphorylation of wt PS1 (Maesako et al. 2010) . APP CTFs band was accumulated in MEF PS-/-cells (Fig. 1A , 1 st lane). Interestingly, in the absence of insulin, the level of APP CTFs was slightly higher in S353/357D PS1 cells than that in wt PS1
( Fig. 1A , 2 nd and 3 rd lanes). Moreover, in the presence of insulin, the level of APP CTFs in S353/357D PS1 was significantly increased compared to that in wt PS1 (Fig. 1A, 4 th and 5 th lanes, Fig. 1B) . Using Tricine gels, we could detect that the level of APP ICD (AICD) in S353/357D PS1 was decreased compared to that in wt PS1 (Fig. 1C, 3 rd and 4 th lanes). This result was confirmed by in vitro γ-secretase assay (Fig. 1D) . Collectively, these results suggested that PS1 phosphorylation inhibited the γ-secretase-mediated cleavage of APP CTFs.
As A plays a pivotal role in the pathogenesis of AD, we next examined the effect of PS1 phosphorylation on extracellular Aproduction, as well as A42/40 ratio. For this purpose, either Akt inhibitor IV or LiCl, which activates or inhibits GSK3 respectivelywas added to change the phosphorylation status of PS1 in APPswe/N-cad-CHO cells (Fig. 1E) . Under this condition, neither of them induced cell death (Fig. 1F) . Interestingly, Akt inhibitor significantly decreased the amount of extracellular A40whereas LiCl significantly increased its amount (Fig. 1G) . In contrast, the extracellular A42level in the presence of either Akt inhibitor or LiCl remained almost the same (Fig. 1H) , thus leading to the increase of A42/40 ratio in Akt inhibitor-treated cells or to the decrease of its ratio in LiCl-treated cells (Fig. 1I) . These results collectively indicate that GSK3mediatedPS1 phosphorylation down-regulated Aproduction but enhanced A ratio.
PS1 phosphorylation is enhanced in AD human brain samples
It was reported that GSK3 activity was up-regulated in AD brains (Bhat et al. 2004) . Therefore, we assumed that the phosphorylation ratio of PS1 might be increased in AD brains. Thus, we analyzed the phosphorylation ratio of PS1 in human brains. In order to rule out the post-mortem effect on the phosphorylation state of PS1 and GSK3, we examined the levels of PS1 and GSK3phosphorylation in mouse brains with different post-mortem intervals and demonstrated that post-mortem intervals did not influence the phosphorylation ratio of either PS1 or GSK3 up to 36 hrs after sacrifice (data not shown). In accordance with the previous reports, the phosphorylation ratio of GSK3 S9 was significantly decreased in AD brains compared with that in control brains ( Fig. 2A, 3 rd and 4 th rows, Fig. 2B ), indicating the hyperactivity of GSK3 in AD brains. In contrast, PS1 phosphorylation was significantly increased in AD brains compared with that in control ones ( Fig. 2A , 1 st and 2 nd rows, Fig. 2C ). These results suggest that up-regulated GSK3 activity could enhance PS1 phosphorylation in AD-affected brains.
PS1 phosphorylation promoted IR cleavage
Since IR is one of key regulators of GSK3 activity, we analyzed the functional relationship between PS1/-secretase activity and IR. It is now reported that γ-secretase processes IR, a main player of insulin signaling, along with other substrates (Kasuga et al. 2007; Marambaud et al. 2002; Okamoto et al. 2001) . As reported previously, ectodomain shedding of IR -subunit by metalloproteases generates a membranous fragment  IR CTF (Fig. 3A, bottom) , which is further cleaved by γ-secretase to produce the intracellular domain  IR ICD (Fig. 4A, bottom) . For the analysis of IR cleavage, we co-transfected either wt PS1 or S353/357D PS1 together with IR into MEF PS-/-cells, followed by insulin treatment. In the absence of insulin, IR CTF level was slightly higher in wt PS1 cells than that in S353/357D PS1 cells (Fig. 3B , 2 nd and 3 rd lanes).
Moreover, insulin treatment led to a robust increase in the level of IR CTF in wt PS1 when compared to that in S353/357D PS1 (Fig. 3B, 4 th and 5 th lanes, Fig. 3C ). In addition, we examined the level of IR ICD using in vitro γ-secretase assay and demonstrated that IR ICD level in S353/357D PS1 cells was higher than that in wt PS1 cells (Fig. 3D) . These results suggested that PS1 phosphorylation enhanced the γ-secretase-mediated cleavage of IR CTF.
Since phosphorylation of PS1 reduces the PS1/N-cadherin/-catenin interaction (Uemura et al. 2007) , we asked whether the PS1 interaction with N-cadherin/-catenin directly affects IR cleavage. To test this, MEF
PS-/-cells were co-transfected with IR and Δ340-350 PS1 (a deletion mutant lacking the loop domain necessary
for the interaction with N-cadherin/-catenin (Uemura et al. 2007) ), followed by insulin treatment. As in S353/357D PS1 transfected cells (Fig. 3E , middle lane), the level of IR CTF in Δ340-350 PS1 transfected cells was significantly decreased compared to that in wt PS1 cells (Fig. 3E , left and right lanes, Fig. 3F ). These findings were also confirmed in neuronal cells (Fig. 3G) . Collectively, these results indicated that dissociation of PS1 from N-cadherin/-catenin as well as phosphorylation of PS1 promotes the cleavage of IR by γ-secretase.
IR intracellular domain up-regulates the transcription of Akt
Several lines of evidence suggest that the cleavage of membrane protein by γ-secretase, known as regulated intramembrane proteolysis (RIP), is linked to intracellular signaling events (Wolfe et al. 2004; Maetzel et al. 2009 ). γ-secretase generates the intracellular domain (ICD) of the membranous proteins, resulting in the release of ICD from the membrane. Some ICDs translocate to the nucleus and act as transcription regulators. IR ICD also translocates to the nucleus (Kasuga et al. 2007) , but its exact function remains unknown.
To examine the cellular consequence of IR-RIP, we transfected IR ICD fused with HA-Tag (Fig. 4A, bottom) into SH-SY5Y cells. Immunostaining with anti-HA antibody revealed that IR ICD was located at the nucleus as in the previous report (Fig. 4B, under panel) , whereas full length IR was located at the cell membrane and in the cytoplasmic region (Fig. 4B, top panel) . In order to analyze the effect of IR ICD translocation into the nucleus we transiently transfected IR ICD into native SH-SY5Y cells. 36 hrs after transfection, mRNA was extracted and analyzed by real-time PCR assay. In this experiment, we focused on the mRNA level of Akt, because Akt plays important roles in IR signaling. Since Akt has three isoforms -Akt 1, 2 and 3, we evaluated mRNA level of all the isoforms. mRNA levels of Akt 1 and 2 were significantly increased in IR ICD transfected cells, compared with those in control cells (Fig. 4C) . The protein level of total Akt was also significantly increased in IR ICD transfected cells 48 hrs after transfection ( Fig. 4D and E) , suggesting marked transactivation of Akt in IR ICD transfected cells. Moreover, under the same condition, we observed that IR ICD reduced GSK3 activity, promoted GSK3 S9 phosphorylation, as well as enhanced Akt levels ( Fig. 4F and G). These results collectively indicate that IR ICD can enhance Akt transcription, followed by the reduction in GSK3 activity.
PS1/γ-secretase-mediated IR cleavage changes the expression level of Akt
To confirm that IR-RIP regulates the transcription of Akt, we modulated IR cleavage in several ways. First, we inhibited γ-secretase activity and observed the expression level of Akt. After a 24 hr DAPT treatment, the level of Akt did not change in SH-SY5Y cells which have little endogenous IR (data not shown). On the other hand, the expression level of Akt was dose-dependently decreased in SH-SY5Y wt IR cells (Fig.5A , top row),
indicating that inhibition of γ-secretase led to decrease the levels of Akt. These results were confirmed by the treatment with another γ-secretase inhibitor, L-685458 (data not shown), and by non-pharmacological inhibition (Fig. 5B , middle and right lanes), using D385A PS1, which dominant-negatively inhibits γ-secretase activity (Uemura et al. 2003) .
It was reported that IR might undergo ectodomain shedding by metalloproteases such as ADAM 17 (Kasuga et al. 2007) . Since protein kinase C activation enhances the metalloprotease-mediated ectodomain 14 shedding (Ni et al. 2001) , we treated SH-SY5Y wt IR cells with 500 nM TPA to enhance the ectodomain shedding. In the presence of L-685458, TPA treatment for 24 hrs increased the level of IR CTF, indicating that ectodomain shedding of IR was promoted by TPA ( Fig. 5C . 3 rd and 5 th lanes). To analyze its effect on Akt levels, SH-SY5Y wt IR cells were pre-incubated with either DAPT or vehicle (DMSO) for 18 hrs, followed by TPA treatment with or without DAPT. Interestingly, in the absence of DAPT, the expression level of Akt was increased (Fig. 5D , 5 th lane, Fig. 5E ). Conversely, TPA treatment in the presence of DAPT significantly decreased the level of Akt (Fig. 5D , 4 th and 6 th lanes). Similarly, treatment with PKC inhibitor for 24 hrs in different concentrations demonstrated the dose-dependent decrease of Akt levels (data not shown). Taken together, these results indicate that γ-secretase-mediated IR cleavage generates IR ICD, which then transactivates Akt.
Discussion
Previous reports demonstrated that GSK3 activity is up-regulated in AD brains (Bhat et al. 2004) . On the other hand, conditional transgenic mice overexpressing GSK3in the adult brain show clear evidence of neurodegeneration (Lucas et al. 2001) . Moreover, aberrantly activated GSK3 phosphorylates Tau, which leads to NFTs (Hanger et al. 1992) . This evidence clearly indicated that GSK3plays essential roles in the pathology of AD. Importantly, we and other groups previously reported that PS1, a causative molecule of familial AD, was also phosphorylated by GSK3 at serine 353, 357 residues (Kirschenbaum et al. 2001 , Twomey et al. 2006 , Uemura et al. 2007 . Since most of the familial AD-linked PS1 mutations affect APP metabolism, in the present study, we examined the effect of PS1 phosphorylation on APP cleavage by PS1/-secretase Our analysis using S353/357D mutant PS1 revealed that phosphorylated PS1 significantly inhibited the cleavage of APP CTFs by -secretase (Fig. 1A-D) . Furthermore, the ELISA results indicated that PS1 phosphorylation reduced extracellular A40levels without changing extracellular Alevels, thereby increasing the A ratio ( Fig. 1E-G) . Similar phenomena were observed in the familial AD-linked PS1 mutations (Selkoe and Wolfe 2007) . Accumulating evidence suggests that partial loss of function in γ-secretase may lead to an increased Aratio as well as to neurodegeneration (Shen 2007 , Wolfe 2007 . In addition, a recent report suggested that Amay inhibit Adeposition and thus may be physiologically neuroprotective (Kim et al. 2007 ). Thus, PS1 phosphorylation-mediated reduction of A and increase of A ratio can aggravate the pathology of AD. So far, the significance of PS1 modification including phosphorylation has not yet been fully investigated in AD brains. Importantly, our in vivo study clearly showed accelerated PS1 phosphorylation in sporadic AD patient brains (Fig. 2) . Considering these results, the disruption of the balance of PS1 phosphorylation may lead to neurodegeneration via aberrant GSK3 activity.
In addition, we searched for the mechanisms inhibiting PS1 phosphorylation. In the present study, we found a novel role of γ-secretase-mediated IR cleavage as a protective safeguard from aberrant GSK3 activity. IR is widely distributed in the brain with particularly high concentrations in neurons, both in the cell bodies as well as in synapses (Werther et al. 1987 , Marks et al. 1991 . IR is a known substrate for γ-secretase and IR ICD translocates to the nucleus upon -secretase-mediated cleavage (Kasuga et al. 2007) . In this report, we showed that IR ICD activates the transcription of Akt (Fig. 4) , a key element in multiple biological processes including glucose metabolism, cell survival, cell growth, cell differentiation, and angiogenesis (Franke et al. 2003; Fayard et al. 2005; Song et al. 2005) . Notably, we observed that PS1 phosphorylation promoted the γ-secretase-mediated cleavage of IR (Fig. 3) . Thus, GSK3 activation may promote the phosphorylation of PS1
to enhance cleavage of IR, finally activating the transcription of Akt, which is a strong inhibitor of GSK3
activity. This phenomenon may constitute a negative feedback mechanism, which up-regulates Akt when GSK3 is aberrantly activated. Interestingly, this is contrary to the case of the cleavage of N-cadherin, since N-cadherin cleavage is down-regulated by the phosphorylation of PS1 (Uemura et al. 2007 ). Thus, the phosphorylation status of PS1 may explain in part the substrate specificity in various conditions.
In conclusion, we propose that GSK3-mediatedPS1 phosphorylation, acting as a link between GSK3 activity and A generation, may play a pivotal role in AD pathogenesis under the influence of insulin signaling.
As our study indicated that GSK3-mediated phosphorylation of PS1 increases the A42/40 ratio, modulating GSK3 activity can be a good therapeutic strategy, aiming at both the inhibition of tau phosphorylation and the reduction of A42/40 ratio. Thus, IR cleavage could be one of the potential regulatory mechanisms affecting GSK3 activity as a negative feedback mechanism; disruption of IR cleavage may lead to increased GSK3 activity, as well as A42/40 ratio. Therefore, the in vivo regulatory mechanism of controlling PS1 function including phosphorylation should be examined in future studies.
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